Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus
Abstract APOBEC3 (A3) enzymes are best known for their role as antiviral restriction factors and as mutagens in cancer. Although four of them, A3A, A3B, A3F and A3G, are induced by type-1-interferon (IFN-I), their role in inflammatory conditions is unknown. We thus investigated the expression of A3,...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/85323af00c3940d4aadf6ca47ac55360 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:85323af00c3940d4aadf6ca47ac55360 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:85323af00c3940d4aadf6ca47ac553602021-12-02T18:02:57ZSustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus10.1038/s41598-021-87024-12045-2322https://doaj.org/article/85323af00c3940d4aadf6ca47ac553602021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87024-1https://doaj.org/toc/2045-2322Abstract APOBEC3 (A3) enzymes are best known for their role as antiviral restriction factors and as mutagens in cancer. Although four of them, A3A, A3B, A3F and A3G, are induced by type-1-interferon (IFN-I), their role in inflammatory conditions is unknown. We thus investigated the expression of A3, and particularly A3A and A3B because of their ability to edit cellular DNA, in Systemic Lupus Erythematosus (SLE), a chronic inflammatory disease characterized by high IFN-α serum levels. In a cohort of 57 SLE patients, A3A and A3B, but also A3C and A3G, were upregulated ~ 10 to 15-fold (> 1000-fold for A3B) compared to healthy controls, particularly in patients with flares and elevated serum IFN-α levels. Hydroxychloroquine, corticosteroids and immunosuppressive treatment did not reverse A3 levels. The A3AΔ3B polymorphism, which potentiates A3A, was detected in 14.9% of patients and in 10% of controls, and was associated with higher A3A mRNA expression. A3A and A3B mRNA levels, but not A3C or A3G, were correlated positively with dsDNA breaks and negatively with lymphopenia. Exposure of SLE PBMCs to IFN-α in culture induced massive and sustained A3A levels by 4 h and led to massive cell death. Furthermore, the rs2853669 A > G polymorphism in the telomerase reverse transcriptase (TERT) promoter, which disrupts an Ets-TCF-binding site and influences certain cancers, was highly prevalent in SLE patients, possibly contributing to lymphopenia. Taken together, these findings suggest that high baseline A3A and A3B levels may contribute to cell frailty, lymphopenia and to the generation of neoantigens in SLE patients. Targeting A3 expression could be a strategy to reverse cell death and the generation of neoantigens.Danielle Perez-BercoffHélène LaudeMorgane LemaireOliver HunewaldValérie ThiersMarco VignuzziHervé BlancAurélie PoliZahir AmouraVincent CavalRodolphe SuspèneFrançois HafeziAlexis MathianJean-Pierre VartanianSimon Wain-HobsonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Danielle Perez-Bercoff Hélène Laude Morgane Lemaire Oliver Hunewald Valérie Thiers Marco Vignuzzi Hervé Blanc Aurélie Poli Zahir Amoura Vincent Caval Rodolphe Suspène François Hafezi Alexis Mathian Jean-Pierre Vartanian Simon Wain-Hobson Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus |
| description |
Abstract APOBEC3 (A3) enzymes are best known for their role as antiviral restriction factors and as mutagens in cancer. Although four of them, A3A, A3B, A3F and A3G, are induced by type-1-interferon (IFN-I), their role in inflammatory conditions is unknown. We thus investigated the expression of A3, and particularly A3A and A3B because of their ability to edit cellular DNA, in Systemic Lupus Erythematosus (SLE), a chronic inflammatory disease characterized by high IFN-α serum levels. In a cohort of 57 SLE patients, A3A and A3B, but also A3C and A3G, were upregulated ~ 10 to 15-fold (> 1000-fold for A3B) compared to healthy controls, particularly in patients with flares and elevated serum IFN-α levels. Hydroxychloroquine, corticosteroids and immunosuppressive treatment did not reverse A3 levels. The A3AΔ3B polymorphism, which potentiates A3A, was detected in 14.9% of patients and in 10% of controls, and was associated with higher A3A mRNA expression. A3A and A3B mRNA levels, but not A3C or A3G, were correlated positively with dsDNA breaks and negatively with lymphopenia. Exposure of SLE PBMCs to IFN-α in culture induced massive and sustained A3A levels by 4 h and led to massive cell death. Furthermore, the rs2853669 A > G polymorphism in the telomerase reverse transcriptase (TERT) promoter, which disrupts an Ets-TCF-binding site and influences certain cancers, was highly prevalent in SLE patients, possibly contributing to lymphopenia. Taken together, these findings suggest that high baseline A3A and A3B levels may contribute to cell frailty, lymphopenia and to the generation of neoantigens in SLE patients. Targeting A3 expression could be a strategy to reverse cell death and the generation of neoantigens. |
| format |
article |
| author |
Danielle Perez-Bercoff Hélène Laude Morgane Lemaire Oliver Hunewald Valérie Thiers Marco Vignuzzi Hervé Blanc Aurélie Poli Zahir Amoura Vincent Caval Rodolphe Suspène François Hafezi Alexis Mathian Jean-Pierre Vartanian Simon Wain-Hobson |
| author_facet |
Danielle Perez-Bercoff Hélène Laude Morgane Lemaire Oliver Hunewald Valérie Thiers Marco Vignuzzi Hervé Blanc Aurélie Poli Zahir Amoura Vincent Caval Rodolphe Suspène François Hafezi Alexis Mathian Jean-Pierre Vartanian Simon Wain-Hobson |
| author_sort |
Danielle Perez-Bercoff |
| title |
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus |
| title_short |
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus |
| title_full |
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus |
| title_fullStr |
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus |
| title_full_unstemmed |
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus |
| title_sort |
sustained high expression of multiple apobec3 cytidine deaminases in systemic lupus erythematosus |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/85323af00c3940d4aadf6ca47ac55360 |
| work_keys_str_mv |
AT danielleperezbercoff sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT helenelaude sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT morganelemaire sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT oliverhunewald sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT valeriethiers sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT marcovignuzzi sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT herveblanc sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT aureliepoli sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT zahiramoura sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT vincentcaval sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT rodolphesuspene sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT francoishafezi sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT alexismathian sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT jeanpierrevartanian sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus AT simonwainhobson sustainedhighexpressionofmultipleapobec3cytidinedeaminasesinsystemiclupuserythematosus |
| _version_ |
1718378818548269056 |